APLT - Applied Therapeutics GAAP EPS of -$0.96 misses by $0.40
- Applied Therapeutics press release ( NASDAQ: APLT ): Q2 GAAP EPS of -$0.96 misses by $0.40 .
- Cash and cash equivalents and short-term investments totaled $67.7 million as of June 30, 2022, compared with $80.8 million at December 31, 2021.
For further details see:
Applied Therapeutics GAAP EPS of -$0.96 misses by $0.40